Viji Sankaranarayanan

Title: Viji Sankaranarayanan: Innovator in Anti-Cancer Research

Introduction

Viji Sankaranarayanan is a prominent inventor based in Richmond, VA (US). She has made significant contributions to the field of cancer research, particularly in developing innovative therapeutic agents. Her work focuses on creating compounds that selectively target cancer stem cells, which are often resistant to conventional treatments.

Latest Patents

Viji holds a patent for "Lipidic analogs of anti-cancer stem cell agent." This patent describes a group of specific sulfated flavonoid agents that carry cholesterol modifications. These compounds exhibit promising in vivo anti-cancer activity through selective inhibition of cancer stem cells, while sparing adult or hematopoietic stem cells. The agents demonstrate high potency, excellent oral bioavailability, and a physiologically relevant therapeutic window. She has 1 patent to her name.

Career Highlights

Viji is affiliated with Virginia Commonwealth University, where she conducts her research. Her work has garnered attention for its potential to revolutionize cancer treatment by targeting the root causes of cancer rather than just the symptoms.

Collaborations

Some of her notable coworkers include Umesh R Desai and Balaji Nagarajan, who contribute to her research efforts and help advance the understanding of cancer therapies.

Conclusion

Viji Sankaranarayanan is a trailblazer in the field of anti-cancer research, with her innovative approaches paving the way for new treatment options. Her dedication to developing effective therapies highlights the importance of targeted cancer treatments in improving patient outcomes.